Cover Image

Remyelination in Multiple Sclerosis: the therapeutic potential of neural and mesenchymal stem/progenitor cells

Multiple sclerosis (MS) is a demyelinating immune-mediated disease of the central nervous system (CNS). It is the most common cause of acquired disability in young adults and affects over 2 Mio people worldwide. Current treatments target primarily the immune system, reduce the relapse rate and the f...

Full description

Saved in:
Bibliographic Details
Main Authors: Rivera, Francisco J. (Author) , Kraus, Jörg (Author) , Steffenhagen, Carolin (Author) , Kury, Patrick (Author) , Weidner, Norbert (Author) , Aigner, Ludwig (Author)
Format: Article (Journal)
Language:English
Published: 2011
In: Current signal transduction therapy
Year: 2011, Volume: 6, Issue: 3, Pages: 293-313
DOI:10.2174/157436211797483994
Online Access:Verlag, lizenzpflichtig, Volltext: https://dx.doi.org/10.2174/157436211797483994
Get full text
Author Notes:Francisco J. Rivera, Jorg Kraus, Carolin Steffenhagen, Patrick Kury, Norbert Weidner and Ludwig Aigner

MARC

LEADER 00000caa a22000002c 4500
001 1816867780
003 DE-627
005 20230710114736.0
007 cr uuu---uuuuu
008 220916s2011 xx |||||o 00| ||eng c
024 7 |a 10.2174/157436211797483994  |2 doi 
035 |a (DE-627)1816867780 
035 |a (DE-599)KXP1816867780 
035 |a (OCoLC)1389788692 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rivera, Francisco J.  |e VerfasserIn  |0 (DE-588)1156432243  |0 (DE-627)1019261609  |0 (DE-576)502186682  |4 aut 
245 1 0 |a Remyelination in Multiple Sclerosis  |b the therapeutic potential of neural and mesenchymal stem/progenitor cells  |c Francisco J. Rivera, Jorg Kraus, Carolin Steffenhagen, Patrick Kury, Norbert Weidner and Ludwig Aigner 
264 1 |c 2011 
300 |a 21 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.09.2022 
520 |a Multiple sclerosis (MS) is a demyelinating immune-mediated disease of the central nervous system (CNS). It is the most common cause of acquired disability in young adults and affects over 2 Mio people worldwide. Current treatments target primarily the immune system, reduce the relapse rate and the formation of inflammatory lesions in the CNS, however with only temporary and limited success. Unfortunately, self-repair mechanisms of the CNS have been largely neglected in the past. The identification of neural and oligodendroglial progenitors in the brain and spinal cord, however, evoked the hypothesis that remyelination might be achieved through the activation of endogenous progenitors leading ultimately to functional recovery of the patient. Indeed, spontaneous remyelination is a common feature in MS, at least in the early phases of the disease, however, its levels and its qualities are apparently insufficient for a sustained endogenous functional repair. Here, we review the current knowledge on remyelination mechanisms and describe recent developments on molecular as well as on neural and mesenchymal stem cell therapies for MS treatment. 
700 1 |a Kraus, Jörg  |e VerfasserIn  |4 aut 
700 1 |a Steffenhagen, Carolin  |e VerfasserIn  |4 aut 
700 1 |a Kury, Patrick  |e VerfasserIn  |4 aut 
700 1 |a Weidner, Norbert  |e VerfasserIn  |0 (DE-588)1035265907  |0 (DE-627)747116326  |0 (DE-576)176492577  |4 aut 
700 1 |a Aigner, Ludwig  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Current signal transduction therapy  |d Sharjah, U.A.E. : Bentham Science Publ., 2006  |g 6(2011), 3, Seite 293-313  |h Online-Ressource  |w (DE-627)51191718X  |w (DE-600)2235174-7  |w (DE-576)306833484  |7 nnas  |a Remyelination in Multiple Sclerosis the therapeutic potential of neural and mesenchymal stem/progenitor cells 
773 1 8 |g volume:6  |g year:2011  |g number:3  |g pages:293-313  |g extent:21  |a Remyelination in Multiple Sclerosis the therapeutic potential of neural and mesenchymal stem/progenitor cells 
856 4 0 |u https://dx.doi.org/10.2174/157436211797483994  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220916 
993 |a Article 
994 |a 2011 
998 |g 1035265907  |a Weidner, Norbert  |m 1035265907:Weidner, Norbert  |d 910000  |d 911460  |e 910000PW1035265907  |e 911460PW1035265907  |k 0/910000/  |k 1/910000/911460/  |p 5 
999 |a KXP-PPN1816867780  |e 4189358185 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 16.09.2022"],"person":[{"family":"Rivera","roleDisplay":"VerfasserIn","given":"Francisco J.","role":"aut","display":"Rivera, Francisco J."},{"role":"aut","display":"Kraus, Jörg","given":"Jörg","family":"Kraus","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Steffenhagen, Carolin","given":"Carolin","roleDisplay":"VerfasserIn","family":"Steffenhagen"},{"role":"aut","display":"Kury, Patrick","given":"Patrick","roleDisplay":"VerfasserIn","family":"Kury"},{"roleDisplay":"VerfasserIn","family":"Weidner","display":"Weidner, Norbert","role":"aut","given":"Norbert"},{"family":"Aigner","roleDisplay":"VerfasserIn","role":"aut","display":"Aigner, Ludwig","given":"Ludwig"}],"physDesc":[{"extent":"21 S."}],"relHost":[{"part":{"extent":"21","volume":"6","issue":"3","year":"2011","text":"6(2011), 3, Seite 293-313","pages":"293-313"},"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"pubHistory":["1.2006 -"],"recId":"51191718X","disp":"Remyelination in Multiple Sclerosis the therapeutic potential of neural and mesenchymal stem/progenitor cellsCurrent signal transduction therapy","title":[{"title":"Current signal transduction therapy","title_sort":"Current signal transduction therapy"}],"origin":[{"dateIssuedDisp":"2006-","dateIssuedKey":"2006","publisher":"Bentham Science Publ.","publisherPlace":"Sharjah, U.A.E."}],"id":{"zdb":["2235174-7"],"eki":["51191718X"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 03.07.2023"]}],"id":{"doi":["10.2174/157436211797483994"],"eki":["1816867780"]},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011"}],"title":[{"title_sort":"Remyelination in Multiple Sclerosis","subtitle":"the therapeutic potential of neural and mesenchymal stem/progenitor cells","title":"Remyelination in Multiple Sclerosis"}],"recId":"1816867780","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Francisco J. Rivera, Jorg Kraus, Carolin Steffenhagen, Patrick Kury, Norbert Weidner and Ludwig Aigner"]}} 
SRT |a RIVERAFRANREMYELINAT2011 

Similar Items